Aurora Cannabis Inc. (NASDAQ:ACB – Free Report) – Equities research analysts at Atb Cap Markets cut their Q3 2025 earnings per share (EPS) estimates for Aurora Cannabis in a research report issued to clients and investors on Monday, December 16th. Atb Cap Markets analyst F. Gomes now forecasts that the company will earn ($0.13) per share for the quarter, down from their prior estimate of ($0.09). The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.02) per share. Atb Cap Markets also issued estimates for Aurora Cannabis’ Q4 2025 earnings at ($0.10) EPS, FY2025 earnings at ($0.10) EPS, FY2026 earnings at ($0.16) EPS, FY2027 earnings at ($0.01) EPS and FY2029 earnings at $0.40 EPS.
A number of other equities research analysts have also weighed in on the company. TD Cowen initiated coverage on Aurora Cannabis in a research report on Wednesday, December 11th. They issued a “buy” rating on the stock. TD Securities raised Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th.
Aurora Cannabis Stock Down 5.1 %
Shares of NASDAQ:ACB opened at $4.24 on Thursday. The stock’s 50-day moving average is $4.94 and its 200 day moving average is $5.49. The company has a market cap of $232.53 million, a PE ratio of -5.58 and a beta of 1.86. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.83 and a quick ratio of 1.88. Aurora Cannabis has a 1 year low of $2.84 and a 1 year high of $9.35.
Hedge Funds Weigh In On Aurora Cannabis
A number of institutional investors have recently bought and sold shares of the stock. TD Asset Management Inc bought a new position in Aurora Cannabis in the second quarter worth $255,000. Headlands Technologies LLC grew its position in shares of Aurora Cannabis by 98.8% in the 2nd quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock worth $346,000 after buying an additional 37,269 shares during the period. Tidal Investments LLC grew its position in shares of Aurora Cannabis by 2.7% in the 3rd quarter. Tidal Investments LLC now owns 1,344,321 shares of the company’s stock worth $7,905,000 after buying an additional 34,988 shares during the period. Mackenzie Financial Corp purchased a new position in Aurora Cannabis during the 2nd quarter valued at about $113,000. Finally, Toronto Dominion Bank lifted its position in Aurora Cannabis by 34,356.4% during the 2nd quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock valued at $88,000 after acquiring an additional 18,896 shares during the period. 47.63% of the stock is owned by institutional investors.
Aurora Cannabis Company Profile
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Articles
- Five stocks we like better than Aurora Cannabis
- What is Forex and How Does it Work?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- How to Most Effectively Use the MarketBeat Earnings Screener
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Trading Stocks: RSI and Why it’s Useful
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.